After experiencing success in the Vancouver, WA location, owners of Bud Hut retail stores have entered into an agreement with POSaBIT Inc. (CSE:PBIT) to implement POSaBIT’s Point of Sale platform in the remaining ten WA State Bud Hut locations. Locally owned and operated, Bud Hut has established themselves as one of Washington State’s strongest retail brands.

“Bud Hut independent owner’s collective goal is to always create a superior customer shopping experience. With that objective in mind, we evaluated many POS systems, and found POSaBIT to be the clear leader in creating that connection, along with providing the tools to more efficiently operate our stores,” said Greg Wright, owner of three Bud Hut locations. “POSaBIT’s built in loyalty program, best in class reporting and analytics, enterprise features, ease of use, and integrated payment processing, made POSaBIT the obvious choice. Additionally, the day-of transition to the POSaBIT POS was seamless, quick, and utterly painless.”

POSaBIT’s unique and innovative POS provides solutions for cannabis retailers in myriad ways. The robust feature set combined with a powerful back end reporting suite has allowed stores to maximize their sales and operational efficiency all across the country. A new Mobile POS offering has given dispensaries an additional solution uniquely suited for a modern retail experience.

POSaBIT is thrilled to work with the Bud Hut branded locations in our home state of Washington,” said Jon Baugher, Chief Revenue Officer and Co-Founder of POSaBIT. “Bud Hut knows how to leverage technology to keep their customers informed, provide better product selection, and make smarter business decisions. We are proud to align with them in support of those objectives.”


POSaBIT (CSE: PBIT) is a financial technology company that delivers unique and innovative blockchain-enabled payment processing and point-of-sale systems for cash-only businesses. POSaBIT specializes in resolving pain points for complex, high-risk, emerging industries like cannabis with an all-in-one solution that is compliant, user-friendly and utilizes top-of-the-line hardware. POSaBIT’s unique solution provides a safe and transparent environment for merchants while creating a better overall experience for the consumer. For additional information, visit:

Media Relations:
Oscar Dahl

Ryan Hamlin
Co-founder and CEO of POSaBIT

Copyright Business Wire 2020

News Provided by Business Wire via QuoteMedia

Trading resumes in:

Company: Revive Therapeutics Ltd.

Keep reading... Show less


Revive Therapeutics Ltd. (” Revive ” or the ” Company “) (CSE:RVV) ( USA : RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has entered into an amended agreement with Canaccord Genuity Corp. and Leede Jones Gable Inc. as the co-lead underwriters (collectively, the ” Underwriters “), to increase the size of its previously announced offering of units (the ” Equity Units “) at a price of $0.50 per Equity Unit. Under the amended terms, the Underwriters have agreed to purchase, on a bought deal basis, 40,000,000 Equity Units for gross proceeds to the Company of $20,000,000 (the ” Offering “). The over-allotment option granted to the Underwriters will proportionately increase to 15% of the Offering.

Keep reading... Show less

The new dispensary brings expanded access for patients in the growing communities of Central Florida

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 77th nationwide. The new, 5,100 sq. ft. location marks the Company’s first in Summerfield expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”).

The Company announced today that its board of directors have approved a private placement of up to 15,000,000 units at a price of $.40 per unit for gross proceeds of up to $6,000,000. Each unit will consist of one common share of the Company and one share purchase warrant. Each share purchase warrant will be exercisable to purchase an additional common share at a fixed price of $.45 per share for a period of one year from closing.

Keep reading... Show less

The following issues have been halted by IIROC:

Company: Revive Therapeutics Ltd.

Keep reading... Show less